Alnylam Pharmaceuticals
ALNY
#485
Rank
A$73.13 B
Marketcap
A$553.55
Share price
-6.87%
Change (1 day)
31.92%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company